Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice

Vaccine

Volumn 31, Issue 13, 2013, Pages 1734-1739

  Chen, Jia ^a,b   Huang, Si Yang ^a   Li, Zhong Yuan ^a,b   Yuan, Zi Guo ^a,b   Zhou, Dong Hui ^a   Petersen, Eskild ^c   Zhang, Nian Zhang ^a   Zhu, Xing Quan ^a,d  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^c AARHUS UNIVERSITY   (Denmark)

^d HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

Author keywords

DNA vaccine; EIF4A; Mice; Protective immunity; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INITIATION FACTOR 4A; INTERLEUKIN 2; PVAX EIF4A; RECOMBINANT DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTE; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EUKARYOTIC INITIATION FACTOR-4A; FEMALE; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE SUBSETS; MICE; PROTOZOAN VACCINES; SURVIVAL ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

EID: 84875272058     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.027     Document Type: Article

References (41)

1. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
2. Dubey J.P. Toxoplasmosis of animals and humans 2010, CRC Press Inc., Boca Raton, FL, p.1-313. 2nd ed.
3. Zhou P., Chen Z., Li H.L., Zheng H., He S., Lin R.Q., et al. Toxoplasma gondii infection in humans in China. Parasit Vectors 2011, 4:165.
4. Robert-Gangneux F., Dardé M.L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012, 25:264-296.
5. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000, 30:1217-1258.
6. Weiss L.M., Dubey J.P. Toxoplasmosis: a history of clinical observations. Int J Parasitol 2009, 39:895-901.
7. Innes E.A. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?. Expert Rev Vaccines 2010, 9:1117-1119.
8. Fayer R., Dubey J.P., Lindsay D.S. Zoonotic protozoa: from land to sea. Trends Parasitol 2004, 20:531-536.
9. Dubey J.P., Hill D.E., Jones J.L., Hightower A.W., Kirkland E., Roberts J.M., et al. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J Parasitol 2005, 91:1082-1093.
10. Innes E.A., Vermeulen A.N. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 2006, 133:S145-S168.
11. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., et al. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 2007, 56:263-268.
12. Gurunathan S., Klinman D., Seder R.A. DNA vaccines: immunology, application and optimization. Annu Rev Immunol 2000, 18:927-974.
13. Hoft D.F., Eickhoff C.S., Giddings O.K., Vasconcelos J.R., Rodrigues M.M. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J Immunol 2007, 179:6889-6900.
14. Cherif M.S., Shuaibu M.N., Kurosaki T., Helegbe G.K., Kikuchi M., Yanagi T., et al. Immudnogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration. Vaccine 2011, 29:9038-9050.
15. Gazzinelli R.T., Hieny S., Wynn T.A., Wolf S., Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA. 1993, 90:6115-6119.
16. Garcia J.L. Vaccination concepts against Toxoplasma gondii. Expert Rev Vaccines 2009, 8:215-225.
17. Bhadra R., Gigley J.P., Weiss L.M., Khan I.A. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci USA 2011, 108:9196-9201.
18. Johnson L.L., Sayles P.C. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect Immun 2002, 70:185-191.
19. Bottley A., Phillips N.M., Webb T.E., Willis A.E., Spriggs K.A. eIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's disease. PLoS ONE 2010, 5:e13030.
20. Spriggs K.A., Cobbold L.C., Jopling C.L., Cooper R.E., Wilson L.A., Stoneley M., et al. Canonical initiation factor requirements of the Myc family of internal ribosome entry segments. Mol Cell Biol 2009, 29:1565-1574.
21. Gastens M.H., Fischer H.G. Toxoplasma gondii eukaryotic translation initiation factor 4A associated with tachyzoite virulence is down-regulated in the bradyzoite stage. Int J Parasitol 2002, 32:1225-1234.
22. Tuteja R., Pradhan A. PfeIF4E and PfeIF4A colocalize and their double-stranded RNA inhibits Plasmodium falciparum proliferation. Commun Integr Biol 2010, 3:611-613.
23. Tuteja R., Pradhan A. Isolation and functional characterization of eIF4F components and poly(A)-binding protein from Plasmodium falciparum. Parasitol Int 2009, 58:481-485.
24. Yuan Z.G., Zhang X.X., Lin R.Q., Petersen E., He S., Yu M., et al. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 2011, 29:6614-6619.
25. Bounous D.I., Campagnoli R.P., Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 1992, 36:1022-1027.
26. Kur J., Holec-Gasior L., Hiszczyńska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Rev Vaccines 2009, 8:791-808.
27. Robinson H.L. DNA vaccines: basic mechanism and immune responses. Int J Mol Med 1999, 4:549-555.
28. Beghetto E., Nielsen H.V., Del Poto P., Buffolano W., Guglietta S., Felici F., et al. A combination of antigenic regions of Toxoplasma gondii microneme proteins induce protective immunity against oral infections with parasite cysts. J Infect Dis 2005, 191:637-645.
29. Peng G.H., Yuan Z.G., Zhou D.H., He X.H., Liu M.M., Yan C., et al. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009, 27:6570-6574.
30. Liu M.M., Yuan Z.G., Peng G.H., Zhou D.H., He X.H., Yan C., et al. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res 2010, 106:1079-1084.
31. Yuan Z.G., Zhang X.X., He X.H., Petersen E., Zhou D.H., He Y., et al. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clin Vaccine Immunol 2011, 18:119-124.
32. Yan H.K., Yuan Z.G., Petersen E., Zhang X.X., Zhou D.H., Liu Q., et al. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Exp Parasitol 2011, 128:38-43.
33. Cui X., Lei T., Yang D., Hao P., Li B., Liu Q. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis. Vaccine 2012, 30:2282-2287.
34. Tan F., Hu X., Luo F.J., Pan C.W., Chen X.G. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II. Vaccine 2011, 29:2742-2748.
35. Rashid I., Hedhli D., Moiré N., Pierre J., Debierre-Grockiego F., Dimier-Poisson I., et al. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis. Vaccine 2011, 29:8838-8846.
36. Munoz M., Liesenfeld O., Heimesaat M.M. Immunology of Toxoplasma gondii. Immunol Rev 2011, 240:269-285.
37. Kang H., Remington J.S., Suzuki Y. Decreased resistance of B cell deficient mice to infection with T. gondii despite unimpaired expression of IFN-gamma, TNF-alfa and inducible nitric oxide synthase. J Immunol 2000, 164:2629-2634.
38. Sibley L.D., Adams L.B., Krahenbuhl J.L. Macrophage interactions in toxoplasmosis. Res Immunol 1993, 144:38-40.
39. Angus C.W., Klivington-Evans D., Dubey J.P., Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (SAG1) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 2000, 181:317-324.
40. Fang R., Nie H., Wang Z.S., Tu P., Zhou D., Wang L.X., et al. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet Parasitol 2009, 164:134-140.
41. Sibley L.D., Ajioka J.W. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu Rev Microbiol 2008, 62:329-351.